FDA Approved: NELARABINE — Original Application (Meitheal Pharmaceuticals Inc)

View source ↗

Summary

FDA approves Meitheal Pharmaceuticals' nelarabine original application (ANDA216038) for a generic formulation of nelarabine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Acute Lymphoblastic Leukemia
• T-cell Lymphoblastic Lymphoma

Drugs mentioned

• Nelarabine (Nelarabine)

Snippet

ORIG AP for NELARABINE (NELARABINE)